Corbus Pharmaceuticals Holdings (CRBP) Interest Coverage Ratio (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Interest Coverage Ratio of 6.5 for Q1 2025, up 43.29% year-over-year from 4.54 in Q1 2024, and down 103.72% quarter-over-quarter from 175.07 in Q4 2024.
Corbus Pharmaceuticals Holdings (CRBP) Interest Coverage Ratio (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 6.5 for Q1 2025.
- In Q1 2025, Interest Coverage Ratio rose 43.29% year-over-year to 6.5; the TTM figure through Sep 2025 stood at 99.02 (down 457.02% YoY), while the FY2024 annual figure was 17.29, down 3541.25% from the prior year.
- Interest Coverage Ratio for Q1 2025 stood at 6.5, down from 175.07 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 175.07 in Q4 2024, with the low at 22.97 in Q4 2021.
- The 5-year median for Interest Coverage Ratio is 1.14 (2022), against an average of 4.1.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio slumped 2833.31% in 2022, then surged 1175.99% in 2024.
- Corbus Pharmaceuticals Holdings' Interest Coverage Ratio stood at 22.97 in 2021, then jumped by 72.18% to 6.39 in 2022, then plunged by 154.65% to 16.27 in 2023, then surged by 1175.99% to 175.07 in 2024, then slumped by 103.72% to 6.5 in 2025.
- Business Quant data shows CRBP's Interest Coverage Ratio at 6.5 in Q1 2025, 175.07 in Q4 2024, and 5.96 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -6.50 |
| Dec 31, 2024 | 175.07 |
| Sep 30, 2024 | -5.96 |
| Jun 30, 2024 | -0.90 |
| Mar 31, 2024 | -11.47 |
| Dec 31, 2023 | -16.27 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | -18.46 |
| Dec 31, 2022 | -6.39 |
| Sep 30, 2022 | -0.75 |
| Jun 30, 2022 | -1.14 |
| Mar 31, 2022 | -12.45 |
| Dec 31, 2021 | -22.97 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.45 |
| Mar 31, 2021 | -0.42 |
| Dec 31, 2020 | -31.22 |
| Sep 30, 2020 | -0.99 |
| Jun 30, 2020 | -1.22 |